Company profile
CorMedix Inc.
NASDAQ: CRMD · Healthcare · Biotechnology
PublicHQ Berkeley Heights, NJCIK 0001410098Reports USD
#244 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
75B+FH 84DQ 66GM 65SS 72
v0.1 · 65/100 weight · provisional
↑ operating margin, 3-yr revenue growth · ↓ growth stability, filing timeliness
Methodology →Revenue TTM
$400.1M
Rev growth YoY (TTM)
+384.6%
Net income (FY)
$163.1M
Employees
191
as of 2026-08-11
Market cap
$590.7M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$311.7M$311.7M2025
Net income$163.1M$163.1M2025
Operating income$150.1M$150.1M2025
Total assets$826.1M$826.1M2025
Liabilities$420.8M$420.8M2025
Equity$405.3M$405.3M2025
Revenue trend
FY2017 – FY2025 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product100%
By geography
Not disclosed.
The read
What is CorMedix Inc.’s revenue?
CorMedix Inc. booked $311.7M in FY2025 revenue, growing 617% year over year — faster than 95% of Healthcare companies we track, at a 52.3% net margin.
Peers · Healthcare
DocGo Inc.44DKnight Therapeutics Inc.77B+Eagle Pharmaceuticals, Inc.——Health Catalyst, Inc.56CPROCEPT BioRobotics Corporation63CBillionToOne, Inc.53DKey facts
CEOJoseph Todisco
SectorHealthcare
IndustryBiotechnology
HeadquartersBerkeley Heights, NJ
ExchangeNASDAQ: CRMD
Employees191
IPO date2010-05-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.